logo
The Report of the Institute of Medicine on Drug Safety
The Hypertension Peril and Drug Development
Thromboembolic Cardiovascular Risk Among Arthritis Patients Using Cyclooxygenase-2-Selective Inhibitor or Nonselective Cyclooxygenase Inhibitor Nonsteroidal Anti-inflammatory Drugs
MK-0703 (a Cyclooxygenase-2 inhibitor) in Acute Pain Associated with Dental Surgery: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Dose-Ranging Study
Better Patient Persistence With Once-Daily Bupropion Compared With Twice-Daily Bupropion
The Evaluation of the Diuretic Action of Parenteral Formulations of Metolazone
The CoPrescription of Contraindicated Drugs With Statins: Continuing Potential for Increased Risk of Adverse Events
Statins Ameliorate Glomerular Permeability Changes in Streptozotocin-Induced Diabetic Rats
One-Year Mean Follow-up of 41 Patients Treated With Bifurcation Stenting
Dual PPAR α/γ Agonists: Promises and Pitfalls in Type 2 Diabetes
Recurrent Headache as the Main Symptom of Acquired Cerebral Toxoplasmosis in Nonhuman Immunodeficiency Virus-infected Subjects With no Lymphadenopathy
Hematologic Adverse Effects of Clopidogrel
Low-grade Non-Hodgkin Lymphoma at Advanced Stage: A Case Successfully Treated With Cyclophosphamide Plus Somatostatin, Bromocriptine, Retinoids, and Melatonin
Oxaliplatin Hypersensitivity: Case Report and Successful Repeat Desensitization